BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 31881138)

  • 21. Human schistosomiasis in Benin: Countrywide evidence of Schistosoma haematobium predominance.
    Onzo-Aboki A; Ibikounlé M; Boko PM; Savassi BS; Doritchamou J; Siko EJ; Daré A; Batcho W; Massougbodji A; Tougoue JJ; Kaboré A
    Acta Trop; 2019 Mar; 191():185-197. PubMed ID: 30633895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of Different Mass Drug Administration Strategies for Gaining and Sustaining Control of
    King CH; Kittur N; Binder S; Campbell CH; N'Goran EK; Meite A; Utzinger J; Olsen A; Magnussen P; Kinung'hi S; Fenwick A; Phillips AE; Gazzinelli-Guimaraes PH; Dhanani N; Ferro J; Karanja DMS; Mwinzi PNM; Montgomery SP; Wiegand RE; Secor WE; Hamidou AA; Garba A; Colley DG
    Am J Trop Med Hyg; 2020 Jul; 103(1_Suppl):14-23. PubMed ID: 32400356
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and risk factors of Schistosoma mansoni infection among preschool-aged children from Panamasso village, Burkina Faso.
    Cisse M; Sangare I; Djibougou AD; Tahita MC; Gnissi S; Bassinga JKW; Konda S; Diallo AH
    Parasit Vectors; 2021 Apr; 14(1):185. PubMed ID: 33794961
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of praziquantel and reinfection patterns in single and mixed infection foci for intestinal and urogenital schistosomiasis in Cameroon.
    Tchuem Tchuenté LA; Momo SC; Stothard JR; Rollinson D
    Acta Trop; 2013 Nov; 128(2):275-83. PubMed ID: 23791803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessing the benefits of five years of different approaches to treatment of urogenital schistosomiasis: A SCORE project in Northern Mozambique.
    Phillips AE; Gazzinelli-Guimaraes PH; Aurelio HO; Ferro J; Nala R; Clements M; King CH; Fenwick A; Fleming FM; Dhanani N
    PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006061. PubMed ID: 29220347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Micro-geographical heterogeneity in Schistosoma mansoni and S. haematobium infection and morbidity in a co-endemic community in northern Senegal.
    Meurs L; Mbow M; Boon N; van den Broeck F; Vereecken K; Dièye TN; Abatih E; Huyse T; Mboup S; Polman K
    PLoS Negl Trop Dis; 2013; 7(12):e2608. PubMed ID: 24386499
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Population genetic structure of Schistosoma mansoni and Schistosoma haematobium from across six sub-Saharan African countries: implications for epidemiology, evolution and control.
    Gower CM; Gouvras AN; Lamberton PH; Deol A; Shrivastava J; Mutombo PN; Mbuh JV; Norton AJ; Webster BL; Stothard JR; Garba A; Lamine MS; Kariuki C; Lange CN; Mkoji GM; Kabatereine NB; Gabrielli AF; Rudge JW; Fenwick A; Sacko M; Dembelé R; Lwambo NJ; Tchuem Tchuenté LA; Rollinson D; Webster JP
    Acta Trop; 2013 Nov; 128(2):261-74. PubMed ID: 23041540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiology of mixed Schistosoma mansoni and Schistosoma haematobium infections in northern Senegal.
    Meurs L; Mbow M; Vereecken K; Menten J; Mboup S; Polman K
    Int J Parasitol; 2012; 42(3):305-11. PubMed ID: 22366733
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sensitivity of the Point-of-Care Circulating Cathodic Antigen Urine Cassette Test for Diagnosis of
    Assaré RK; Tra MBI; Ouattara M; Hürlimann E; Coulibaly JT; N'Goran EK; Utzinger J
    Am J Trop Med Hyg; 2018 Dec; 99(6):1567-1572. PubMed ID: 30277203
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence and control of Schistosoma haematobium infections in the Amran subprovince of the Yemen Arab Republic.
    Janitschke K; Telher AA; Wachsmuth J; Jahia S
    Trop Med Parasitol; 1989 Jun; 40(2):181-4. PubMed ID: 2505380
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gender-related differences in prevalence, intensity and associated risk factors of Schistosoma infections in Africa: A systematic review and meta-analysis.
    Ayabina DV; Clark J; Bayley H; Lamberton PHL; Toor J; Hollingsworth TD
    PLoS Negl Trop Dis; 2021 Nov; 15(11):e0009083. PubMed ID: 34788280
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and efficacy of praziquantel syrup (Epiquantel®) against Schistosoma haematobium and Schistosoma mansoni in preschool-aged children in Niger.
    Garba A; Lamine MS; Djibo A; Tahirou A; Aouami MA; Alfari A; Phillips AE; Fenwick A; Utzinger J
    Acta Trop; 2013 Nov; 128(2):318-25. PubMed ID: 23237719
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CONTROL OF SCHISTOSOMIASIS IN THE GEZIRA IRRIGATION SCHEME, SUDAN.
    Amin M; Abubaker H
    J Biosoc Sci; 2017 Jan; 49(1):83-98. PubMed ID: 26924236
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluating survey designs for targeting preventive chemotherapy against Schistosoma haematobium and Schistosoma mansoni across sub-Saharan Africa: a geostatistical analysis and modelling study.
    Fornace KM; Fronterrè C; Fleming FM; Simpson H; Zoure H; Rebollo M; Mwinzi P; Vounatsou P; Pullan RL
    Parasit Vectors; 2020 Nov; 13(1):555. PubMed ID: 33203463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The epidemiology of a recent focus of mixed Schistosoma haematobium and Schistosoma mansoni infections around the 'Lac de Guiers' in the Senegal River Basin, Senegal.
    De Clercq D; Vercruysse J; Picquet M; Shaw DJ; Diop M; Ly A; Gryseels B
    Trop Med Int Health; 1999 Aug; 4(8):544-50. PubMed ID: 10499077
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidemiology of pediatric schistosomiasis in hard-to-reach areas and populations: a scoping review.
    Isaiah PM; Sólveig Palmeirim M; Steinmann P
    Infect Dis Poverty; 2023 Apr; 12(1):37. PubMed ID: 37069632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa.
    van der Werf MJ; de Vlas SJ; Brooker S; Looman CW; Nagelkerke NJ; Habbema JD; Engels D
    Acta Trop; 2003 May; 86(2-3):125-39. PubMed ID: 12745133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and associated factors of Schistosomiasis among children in Yemen: implications for an effective control programme.
    Sady H; Al-Mekhlafi HM; Mahdy MA; Lim YA; Mahmud R; Surin J
    PLoS Negl Trop Dis; 2013; 7(8):e2377. PubMed ID: 23991235
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Achieving Elimination as a Public Health Problem for Schistosoma mansoni and S. haematobium: When Is Community-Wide Treatment Required?
    Toor J; Rollinson D; Turner HC; Gouvras A; King CH; Medley GF; Hollingsworth TD; Anderson RM
    J Infect Dis; 2020 Jun; 221(Suppl 5):S525-S530. PubMed ID: 31829414
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interactions between Schistosoma haematobium and Schistosoma mansoni in humans in north Cameroon.
    Cunin P; Tchuem Tchuenté LA; Poste B; Djibrilla K; Martin PM
    Trop Med Int Health; 2003 Dec; 8(12):1110-7. PubMed ID: 14641846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.